Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell cycle process	WAPL CENPC ATAD5 C9orf78 AHCTF1 TOM1L1 KATNB1 BARD1 MSH4 TERF2 KIF20B SETDB2 FBXL7 ALMS1 BRDT PIK3C3 ANLN STARD9 ASPM MASTL TLE6 PRKCB CDC6 CDC20	1.77e-06	1441	118	24	GO:0022402
GeneOntologyBiologicalProcess	cell division	WAPL CENPC AHCTF1 KATNB1 KIF20B SETDB2 FBXL7 PIK3C3 ANLN ASPM MASTL TLE6 CDC6 CDC20 SENP5	1.06e-05	697	118	15	GO:0051301
GeneOntologyBiologicalProcess	nuclear division	WAPL CENPC C9orf78 TOM1L1 KATNB1 MSH4 KIF20B BRDT ANLN ASPM MASTL CDC20	3.78e-05	512	118	12	GO:0000280
GeneOntologyBiologicalProcess	B cell adhesion	CLEC4M CD209	9.70e-05	3	118	2	GO:0097323
GeneOntologyBiologicalProcess	peptide antigen transport	CLEC4M CD209	9.70e-05	3	118	2	GO:0046968
GeneOntologyBiologicalProcess	organelle fission	WAPL CENPC C9orf78 TOM1L1 KATNB1 MSH4 KIF20B BRDT ANLN ASPM MASTL CDC20	1.07e-04	571	118	12	GO:0048285
GeneOntologyCellularComponent	spindle pole	KATNB1 KIF20B FRY ALMS1 ASPM CDC6 CDC20	1.74e-04	205	119	7	GO:0000922
GeneOntologyCellularComponent	cell cortex	CALD1 FRYL AKAP12 C2CD5 FRY ANLN TLE6 PRKCB MACF1	2.76e-04	371	119	9	GO:0005938
GeneOntologyCellularComponent	microtubule organizing center	CCDC14 LRWD1 KATNB1 KIF20B C2CD5 TTBK2 FRY FBXL7 ALMS1 STARD9 ASPM MASTL PRKCB CDC20	7.41e-04	919	119	14	GO:0005815
GeneOntologyCellularComponent	MLL1 complex	KMT2A HCFC2 MGA	7.91e-04	32	119	3	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	KMT2A HCFC2 MGA	8.66e-04	33	119	3	GO:0044665
GeneOntologyCellularComponent	histone methyltransferase complex	AEBP2 KMT2A HCFC2 MGA	8.89e-04	75	119	4	GO:0035097
GeneOntologyCellularComponent	host cell	CLEC4M CD209	1.13e-03	9	119	2	GO:0043657
GeneOntologyCellularComponent	acrosomal vesicle	ITGA1 CFAP65 CRCP CCDC62 SPAG17 VPS13B	1.17e-03	206	119	6	GO:0001669
Domain	Cell_morpho_N	FRYL FRY	3.82e-05	2	116	2	IPR025614
Domain	DUF1088	NBEA LRBA	3.82e-05	2	116	2	IPR010508
Domain	Cell_Morphogen_C	FRYL FRY	3.82e-05	2	116	2	IPR025481
Domain	MOR2-PAG1_mid	FRYL FRY	3.82e-05	2	116	2	IPR029473
Domain	MOR2-PAG1_mid	FRYL FRY	3.82e-05	2	116	2	PF14228
Domain	MOR2-PAG1_C	FRYL FRY	3.82e-05	2	116	2	PF14225
Domain	MOR2-PAG1_N	FRYL FRY	3.82e-05	2	116	2	PF14222
Domain	DUF1088	NBEA LRBA	3.82e-05	2	116	2	PF06469
Domain	WD_REPEATS_1	LRWD1 KATNB1 NBEA NBAS TLE6 LRBA CDC20 WDR72	3.46e-04	278	116	8	PS00678
Domain	WD_REPEATS_2	LRWD1 KATNB1 NBEA NBAS TLE6 LRBA CDC20 WDR72	3.54e-04	279	116	8	PS50082
Domain	WD_REPEATS_REGION	LRWD1 KATNB1 NBEA NBAS TLE6 LRBA CDC20 WDR72	3.54e-04	279	116	8	PS50294
Domain	DUF4704	NBEA LRBA	3.78e-04	5	116	2	IPR031570
Domain	DUF4704	NBEA LRBA	3.78e-04	5	116	2	PF15787
Domain	PH_BEACH	NBEA LRBA	5.64e-04	6	116	2	PF14844
Domain	SPOC_C	PHF3 SPEN	5.64e-04	6	116	2	IPR012921
Domain	SPOC	PHF3 SPEN	5.64e-04	6	116	2	PF07744
Domain	Znf_U1	ZFHX4 ZNF638 ZFHX2	7.58e-04	29	116	3	IPR003604
Domain	ZnF_U1	ZFHX4 ZNF638 ZFHX2	7.58e-04	29	116	3	SM00451
Domain	PI3K_C2	PIK3C2A PIK3C3	1.04e-03	8	116	2	SM00142
Domain	PH-BEACH_dom	NBEA LRBA	1.04e-03	8	116	2	IPR023362
Domain	PI3K_C2_dom	PIK3C2A PIK3C3	1.04e-03	8	116	2	IPR002420
Domain	-	NBEA LRBA	1.04e-03	8	116	2	2.30.29.40
Domain	PI3K_C2	PIK3C2A PIK3C3	1.04e-03	8	116	2	PF00792
Domain	PI3K_C2	PIK3C2A PIK3C3	1.04e-03	8	116	2	PS51547
Domain	PH_BEACH	NBEA LRBA	1.04e-03	8	116	2	PS51783
Domain	-	LRWD1 KATNB1 NBEA NBAS TLE6 LRBA CDC20 WDR72	1.12e-03	333	116	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	LRWD1 KATNB1 NBEA NBAS TLE6 LRBA CDC20 WDR72	1.17e-03	335	116	8	IPR015943
Domain	WD40	LRWD1 KATNB1 NBEA TLE6 LRBA CDC20 WDR72	1.17e-03	259	116	7	PF00400
Domain	MAGE	MAGED1 TRO MAGED2	1.21e-03	34	116	3	SM01373
Domain	ARM-type_fold	WAPL NBEA FRYL TRIP12 PIK3C2A PIK3C3 ASPM LRBA	1.26e-03	339	116	8	IPR016024
Domain	PI3Ka	PIK3C2A PIK3C3	1.34e-03	9	116	2	PF00613
Domain	BEACH	NBEA LRBA	1.34e-03	9	116	2	PS50197
Domain	Beach	NBEA LRBA	1.34e-03	9	116	2	PF02138
Domain	-	NBEA LRBA	1.34e-03	9	116	2	1.10.1540.10
Domain	Beach	NBEA LRBA	1.34e-03	9	116	2	SM01026
Domain	PI3Ka	PIK3C2A PIK3C3	1.34e-03	9	116	2	SM00145
Domain	BEACH_dom	NBEA LRBA	1.34e-03	9	116	2	IPR000409
Domain	-	PIK3C2A PIK3C3	1.34e-03	9	116	2	1.25.40.70
Domain	WD40	LRWD1 KATNB1 NBEA TLE6 LRBA CDC20 WDR72	1.43e-03	268	116	7	SM00320
Domain	MAGE	MAGED1 TRO MAGED2	1.44e-03	36	116	3	PS50838
Domain	MHD_dom	MAGED1 TRO MAGED2	1.44e-03	36	116	3	IPR002190
Domain	MAGE	MAGED1 TRO MAGED2	1.44e-03	36	116	3	PF01454
Domain	WD40_repeat	LRWD1 KATNB1 NBEA TLE6 LRBA CDC20 WDR72	1.56e-03	272	116	7	IPR001680
Domain	C2	CC2D1B C2CD5 PIK3C2A PIK3C3 PRKCB	1.65e-03	137	116	5	SM00239
Domain	PI_Kinase	PIK3C2A PIK3C3	1.67e-03	10	116	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2A PIK3C3	1.67e-03	10	116	2	IPR001263
Domain	PIK_HELICAL	PIK3C2A PIK3C3	1.67e-03	10	116	2	PS51545
Domain	BROMODOMAIN_2	SP110 BRDT KMT2A	2.10e-03	41	116	3	PS50014
Domain	Bromodomain	SP110 BRDT KMT2A	2.25e-03	42	116	3	IPR001487
Domain	BROMO	SP110 BRDT KMT2A	2.25e-03	42	116	3	SM00297
Domain	-	SP110 BRDT KMT2A	2.25e-03	42	116	3	1.20.920.10
Domain	-	CC2D1B C2CD5 PIK3C2A PIK3C3 PRKCB	2.31e-03	148	116	5	2.60.40.150
Domain	WD40_repeat_dom	LRWD1 KATNB1 NBEA TLE6 LRBA CDC20 WDR72	2.55e-03	297	116	7	IPR017986
Domain	fn3	MYLK TNC NCAM1 CMYA5 HCFC2	3.42e-03	162	116	5	PF00041
Domain	C2_dom	CC2D1B C2CD5 PIK3C2A PIK3C3 PRKCB	3.60e-03	164	116	5	IPR000008
Domain	PI3/4_kinase_CS	PIK3C2A PIK3C3	3.81e-03	15	116	2	IPR018936
Domain	-	PIK3C2A PIK3C3	4.34e-03	16	116	2	1.10.1070.11
Domain	PI3Kc	PIK3C2A PIK3C3	4.34e-03	16	116	2	SM00146
Domain	AT_hook	AHCTF1 KMT2A	4.34e-03	16	116	2	PF02178
Domain	PI3_PI4_kinase	PIK3C2A PIK3C3	5.48e-03	18	116	2	PF00454
Domain	PI3_4_KINASE_1	PIK3C2A PIK3C3	5.48e-03	18	116	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C2A PIK3C3	5.48e-03	18	116	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3C2A PIK3C3	5.48e-03	18	116	2	IPR000403
Domain	PI3_4_KINASE_3	PIK3C2A PIK3C3	5.48e-03	18	116	2	PS50290
Domain	FN3	MYLK TNC NCAM1 CMYA5 HCFC2	5.98e-03	185	116	5	SM00060
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	MYLK CALD1 ITGA1 TLN1	6.12e-05	35	87	4	MM15114
Pathway	REACTOME_CELL_CYCLE	VRK2 WAPL CENPC AHCTF1 BARD1 CC2D1B TERF2 FBXL7 ALMS1 MASTL PRKCB CDC6 CDC20	7.84e-05	603	87	13	MM14635
Pathway	REACTOME_CELL_CYCLE	VRK2 WAPL CENPC AHCTF1 BARD1 CC2D1B MSH4 TERF2 FBXL7 ALMS1 MASTL PRKCB CDC6 CDC20	8.27e-05	694	87	14	M543
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	MYLK CALD1 ITGA1 TLN1	1.39e-04	43	87	4	M1429
Pathway	BIOCARTA_MCALPAIN_PATHWAY	MYLK ITGA1 TLN1	2.05e-04	19	87	3	MM1434
Pathway	BIOCARTA_ECM_PATHWAY	MYLK ITGA1 TLN1	2.79e-04	21	87	3	MM1390
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	LRWD1 WAPL CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 TRIP12 KIF20B SETDB2 SCML2 THYN1 ANLN PHF3 MASTL KMT2A MGA SPEN ZNF292	4.20e-14	608	122	20	36089195
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CCDC14 CENPC ATAD5 C9orf78 BARD1 SRP68 TERF2 TRIP12 ALMS1 ANLN TLN1 XRN1 ZNF638 KMT2A LRBA MED26 SPEN	1.25e-10	645	122	17	25281560
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	LRWD1 MAGED1 CALD1 ATAD5 SRP68 TRIP12 AKAP12 SCML2 PIK3C2A PHF3 TLN1 XRN1 MACF1 CDC20 MGA SPEN ZNF292	7.24e-10	724	122	17	36232890
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	C9orf78 SRP68 NCAM1 NBEA TRIP12 AKAP12 TASOR2 PCF11 LIPE MAGED2 XRN1 ZNF638 HCFC2 LRBA MGA SPEN ARAP2	2.09e-09	777	122	17	35844135
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF777 WAPL CALD1 CENPC ATAD5 AHCTF1 ZNF280C TRIP12 KIF20B TASOR2 PCF11 SCML2 ANLN PHF3 ZNF638 KMT2A MGA SPEN	6.78e-09	954	122	18	36373674
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	WAPL CALD1 AHCTF1 SRP68 SCML2 ALMS1 ANLN PHF3 TLN1 XRN1 KMT2A LRBA MGA SPEN	9.10e-09	549	122	14	38280479
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	LRWD1 WAPL CALD1 CENPC C9orf78 AHCTF1 TERF2 AKAP12 TASOR2 PCF11 NBAS TTBK2 ANLN TLN1 ASPM MASTL CDC6 CDC20 VPS13B	2.23e-08	1155	122	19	20360068
Pubmed	Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.	CLEC4M CD209 PIK3C2A PIK3C3 PRKCB	2.46e-08	25	122	5	17632570
Pubmed	Comparative expression analysis of the MAGED genes during embryogenesis and brain development.	MAGED1 TRO MAGED2	4.21e-08	3	122	3	15162511
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	WAPL ERCC5 AHCTF1 FRYL TRIP12 AKAP12 TIAM2 C2CD5 TTBK2 SCML2 ANLN AEBP2 MASTL ZNF638 MACF1 ANKRD12 MGA VPS13B	4.74e-08	1084	122	18	11544199
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	VRK2 WAPL MAGED1 SRP68 NBAS SCML2 THYN1 ALMS1 ANLN PHF3 XRN1 MASTL ZNF638 CDC20 MGA	4.78e-08	733	122	15	34672954
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	WAPL AHCTF1 ZNF280C TRIP12 PCF11 SCML2 PHF3 ZNF638 MGA SPEN	6.71e-08	283	122	10	30585729
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	WAPL C5orf22 ATAD5 AHCTF1 REV3L SP110 C2CD5 SETDB2 ALMS1 ZFHX4 BRDT XRN1 ASPM MACF1 MGA UNC80 ARAP2 WDR72	7.32e-08	1116	122	18	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	LRWD1 WAPL ERCC5 C9orf78 TERF2 TRIP12 C2CD5 PCF11 SCML2 MAGED2 ANLN PHF3 ZNF638 KMT2A SPEN	9.66e-08	774	122	15	15302935
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	WAPL CALD1 ATAD5 AHCTF1 ZNF280C SRP68 AKAP12 SCML2 ALMS1 TLN1 XRN1 MASTL ZNF638 KMT2A MACF1 LRBA	1.86e-07	934	122	16	33916271
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	VRK2 C9orf78 AHCTF1 ZNF280C SCML2 ANLN MASTL	2.49e-07	121	122	7	22412018
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MAGED1 AHCTF1 ALMS1 XRN1 ZNF638 MACF1 LRRC7 LRBA VPS13B	4.09e-07	263	122	9	34702444
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	UTP6 ATAD5 BARD1 SRP68 TERF2 TRIP12 KIF20B MAGED2 PIK3C3 PHF3 XRN1 ASPM MACF1 CDC6	4.81e-07	759	122	14	35915203
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 AHCTF1 SRP68 FRYL TRIP12 TASOR2 PHF3 TLN1 XRN1 ZNF638 KMT2A MACF1 SPEN	5.41e-07	653	122	13	22586326
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	KIF20B TASOR2 PHF3 ZNF638 KMT2A MGA	6.15e-07	86	122	6	37253089
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ERCC5 MYLK CALD1 CENPC TRO CC2D1B TERF2 TRIP12 TASOR2 PCF11 MAGED2 STARD9 XRN1 ASPM KMT2A MACF1 SPAG17 SPEN ZNF292	6.81e-07	1442	122	19	35575683
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	LRWD1 MAGED1 AHCTF1 TERF2 TRIP12 TASOR2 ALMS1 AEBP2 ZNF638 KMT2A SPEN	8.74e-07	469	122	11	27634302
Pubmed	Smooth muscle contraction and relaxation.	MYLK CALD1 ITGA1 TLN1	1.00e-06	22	122	4	14627618
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	VRK2 LRWD1 MAGED1 ATAD5 AHCTF1 SRP68 TERF2 KIF20B PCF11 SCML2 PIK3C2A ANLN PHF3 TLN1 XRN1 KMT2A MACF1 HCFC2 SPEN	1.19e-06	1497	122	19	31527615
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UTP6 LRWD1 WAPL CENPC AHCTF1 SRP68 TRIP12 KIF20B MAGED2 PIK3C2A ANLN TLN1 XRN1 ASPM ZNF638 MACF1 CDC20 MGA	1.21e-06	1353	122	18	29467282
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	LRWD1 WAPL ATAD5 SRP68 TERF2 TRIP12 SCML2 MAGED2 ZNF638 KMT2A	1.39e-06	394	122	10	27248496
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TRO PHF3 STARD9 TLN1 MACF1 LRRC7 ANKRD12 SPEN VPS13B ARAP2	1.86e-06	407	122	10	12693553
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 FRYL TRIP12 ALMS1 PIK3C2A PIK3C3 ANLN PHF3 STARD9 XRN1 KMT2A MACF1 CDC20 ARAP2	2.11e-06	861	122	14	36931259
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	VRK2 LRWD1 ATAD5 AHCTF1 BARD1 TERF2 SP110 TRIP12 SCML2 PHF3 ZNF638 KMT2A HCFC2 CDC6 MGA SPEN MNT	2.91e-06	1294	122	17	30804502
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	EPM2A LRWD1 CENPC ATAD5 TERF2 TRIP12 SCML2 BRDT KMT2A MED26 MGA	3.00e-06	533	122	11	30554943
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TNC RTN3 NCAM1 NBEA C2CD5 PIK3C2A PRKCB MACF1 LRRC7	4.01e-06	347	122	9	17114649
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAGED1 CALD1 MAGED2 ANLN PHF3 TLN1 MASTL MED26 MGA SENP5	4.01e-06	444	122	10	34795231
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CCDC14 ALMS1 PIK3C2A XRN1 ANKRD12 MGA SPEN	4.15e-06	184	122	7	32908313
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TET2 WAPL PCF11 SCML2 ANLN PHF3 KMT2A MGA	5.05e-06	268	122	8	33640491
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	LRWD1 WAPL SRP68 TRIP12 PCF11 MAGED2 ANLN TLN1 ZNF638 MACF1 CDC20	6.90e-06	582	122	11	20467437
Pubmed	Human transcription factor protein interaction networks.	TET2 IKZF3 MAGED1 ATAD5 SRP68 PCF11 ALMS1 ZFHX4 MAGED2 XRN1 ZNF638 KMT2A HCFC2 MGA SPEN MNT SENP5	1.07e-05	1429	122	17	35140242
Pubmed	Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.	CLEC4M CD209	1.22e-05	2	122	2	12351402
Pubmed	Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.	CLEC4M CD209	1.22e-05	2	122	2	25870292
Pubmed	The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.	CLEC4M CD209	1.22e-05	2	122	2	18981244
Pubmed	[Genetic polymorphism of dendritic cell-specific ICAM-3 grabbing nonintegrin and DC-SIGNR's exon 4 in Chinese hepatitis C patients].	CLEC4M CD209	1.22e-05	2	122	2	18171520
Pubmed	Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	12502850
Pubmed	Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	12137941
Pubmed	A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands.	CLEC4M CD209	1.22e-05	2	122	2	11384997
Pubmed	Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.	CLEC4M CD209	1.22e-05	2	122	2	11581396
Pubmed	DC-SIGN and L-SIGN: the SIGNs for infection.	CLEC4M CD209	1.22e-05	2	122	2	18458800
Pubmed	Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.	FRYL KMT2A	1.22e-05	2	122	2	17854671
Pubmed	Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	12634366
Pubmed	The nine-repeat DC-SIGNR isoform is associated with increased HIV-RNA loads and HIV sexual transmission.	CLEC4M CD209	1.22e-05	2	122	2	20217198
Pubmed	Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	15509576
Pubmed	alpha1 Integrin cytoplasmic domain is involved in focal adhesion formation via association with intracellular proteins.	ITGA1 TLN1	1.22e-05	2	122	2	11336656
Pubmed	SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen.	CLEC4M CD209	1.22e-05	2	122	2	23238564
Pubmed	Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals.	CLEC4M CD209	1.22e-05	2	122	2	17876530
Pubmed	Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection.	CLEC4M CD209	1.22e-05	2	122	2	16134084
Pubmed	Polymorphisms in DC-SIGN and L-SIGN genes are associated with HIV-1 vertical transmission in a Northeastern Brazilian population.	CLEC4M CD209	1.22e-05	2	122	2	22902397
Pubmed	C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.	CLEC4M CD209	1.22e-05	2	122	2	12050398
Pubmed	The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?	CLEC4M CD209	1.22e-05	2	122	2	12223058
Pubmed	SIGN-R1 and complement factors are involved in the systemic clearance of radiation-induced apoptotic cells in whole-body irradiated mice.	CLEC4M CD209	1.22e-05	2	122	2	26079881
Pubmed	[Analysis of DC-SIGN and DC-SIGNR genetic polymorphism in Chinese Han population].	CLEC4M CD209	1.22e-05	2	122	2	16883544
Pubmed	The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.	CLEC4M CD209	1.22e-05	2	122	2	25504222
Pubmed	Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junín virus.	CLEC4M CD209	1.22e-05	2	122	2	24183720
Pubmed	High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.	CLEC4M CD209	1.22e-05	2	122	2	15136555
Pubmed	SIGN-R1 contributes to protection against lethal pneumococcal infection in mice.	CLEC4M CD209	1.22e-05	2	122	2	15583012
Pubmed	Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens.	CLEC4M CD209	1.22e-05	2	122	2	15184372
Pubmed	Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic Escherichia coli During Urinary Tract Infections.	CLEC4M CD209	1.22e-05	2	122	2	31998663
Pubmed	Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes.	CLEC4M CD209	1.22e-05	2	122	2	15111305
Pubmed	Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.	CLEC4M CD209	1.22e-05	2	122	2	16365436
Pubmed	Association of CD209 and CD209L polymorphisms with tuberculosis infection in a Northeastern Brazilian population.	CLEC4M CD209	1.22e-05	2	122	2	24874302
Pubmed	Human lectins and their roles in viral infections.	CLEC4M CD209	1.22e-05	2	122	2	25642836
Pubmed	Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	11739956
Pubmed	C-type lectin receptor SIGNR1 expressed on peritoneal phagocytic cells with an immature dendritic cell-like phenotype is involved in uptake of oligomannose-coated liposomes and subsequent cell maturation.	CLEC4M CD209	1.22e-05	2	122	2	24491912
Pubmed	L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.	CLEC4M CD209	1.22e-05	2	122	2	15371595
Pubmed	Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.	CLEC4M CD209	1.22e-05	2	122	2	15795245
Pubmed	Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	19249311
Pubmed	N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN.	CLEC4M CD209	1.22e-05	2	122	2	21191006
Pubmed	Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.	CLEC4M CD209	1.22e-05	2	122	2	17224292
Pubmed	Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.	CLEC4M CD209	1.22e-05	2	122	2	27859859
Pubmed	Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins.	CLEC4M CD209	1.22e-05	2	122	2	16682406
Pubmed	DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.	CLEC4M CD209	1.22e-05	2	122	2	27334579
Pubmed	Difference in fine specificity to polysaccharides of Candida albicans mannoprotein between mouse SIGNR1 and human DC-SIGN.	CLEC4M CD209	1.22e-05	2	122	2	22331432
Pubmed	DC-SIGN and DC-SIGNR polymorphic variants in Northern Asian Indians.	CLEC4M CD209	1.22e-05	2	122	2	19046307
Pubmed	Association of DC-SIGN and DC-SIGNR Repeat Regions with Susceptibility to Pulmonary Tuberculosis in Zahedan, Southeastern Iran.	CLEC4M CD209	1.22e-05	2	122	2	27309478
Pubmed	Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.	CLEC4M CD209	1.22e-05	2	122	2	1518869
Pubmed	Comparison of the carbohydrate preference of SIGNR1 as a phagocytic receptor with the preference as an adhesion molecule.	CLEC4M CD209	1.22e-05	2	122	2	24434373
Pubmed	DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection.	CLEC4M CD209	1.22e-05	2	122	2	24156700
Pubmed	Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.	CLEC4M CD209	1.22e-05	2	122	2	35380569
Pubmed	AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.	FRYL KMT2A	1.22e-05	2	122	2	16061630
Pubmed	DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.	CLEC4M CD209	1.22e-05	2	122	2	12609975
Pubmed	CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.	CLEC4M CD209	1.22e-05	2	122	2	15496474
Pubmed	Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN.	CLEC4M CD209	1.22e-05	2	122	2	18375037
Pubmed	Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR.	CLEC4M CD209	1.22e-05	2	122	2	23460925
Pubmed	Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.	CLEC4M CD209	1.22e-05	2	122	2	26447454
Pubmed	[Relationship between intrauterine infection and the gene polymorphism of DC-SIGN/DC-SIGNR in the pregnant women of HBV positive].	CLEC4M CD209	1.22e-05	2	122	2	22338216
Pubmed	DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility.	CLEC4M CD209	1.22e-05	2	122	2	17509452
Pubmed	HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).	CLEC4M CD209	1.22e-05	2	122	2	19833723
Pubmed	[Natural selection of DC-SIGN and its homologues L-SIGN and mSIGNR1 in pathogen recognition and innate immunity].	CLEC4M CD209	1.22e-05	2	122	2	16386217
Pubmed	The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection.	CLEC4M CD209	1.22e-05	2	122	2	17530994
Pubmed	Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.	CLEC4M CD209	1.22e-05	2	122	2	17715238
Pubmed	Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts.	CLEC4M CD209	1.22e-05	2	122	2	11337487
Pubmed	Determination of DC-SIGN and DC-SIGNR repeat region variations.	CLEC4M CD209	1.22e-05	2	122	2	16061998
Pubmed	COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.	CLEC4M CD209	1.22e-05	2	122	2	32660065
Interaction	TERF2IP interactions	WAPL ERCC5 CENPC ATAD5 C9orf78 AHCTF1 ZNF280C TERF2 TRIP12 KIF20B TASOR2 PCF11 ANLN PHF3 MASTL ZNF638 KMT2A MGA SPEN ZNF292	7.94e-11	552	119	20	int:TERF2IP
Interaction	H2BC8 interactions	VRK2 LRWD1 WAPL ERCC5 CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 TERF2 TRIP12 KIF20B SCML2 ANLN PHF3 KMT2A MGA SPEN ZNF292	1.68e-10	576	119	20	int:H2BC8
Interaction	H3C3 interactions	LRWD1 WAPL CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 TRIP12 KIF20B SCML2 THYN1 ANLN PHF3 KMT2A MGA SPEN ZNF292	7.30e-10	495	119	18	int:H3C3
Interaction	CBX3 interactions	IKZF3 LRWD1 WAPL CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 SP110 TRIP12 SCML2 ANLN PHF3 MASTL KMT2A MACF1 MGA SPEN ZNF292	1.24e-09	646	119	20	int:CBX3
Interaction	H3-3A interactions	LRWD1 WAPL CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 TRIP12 KIF20B SETDB2 SCML2 THYN1 ANLN PHF3 MASTL KMT2A MGA SPEN ZNF292	1.51e-08	749	119	20	int:H3-3A
Interaction	H2BC21 interactions	LRWD1 ATAD5 AHCTF1 ZNF280C BARD1 CC2D1B TERF2 TRIP12 SCML2 PHF3 TLN1 ZNF638 KMT2A PRKCB HCFC2 LMNTD1 ZNF292	7.10e-07	696	119	17	int:H2BC21
Interaction	WWTR1 interactions	WAPL CALD1 AHCTF1 SRP68 SCML2 ALMS1 ANLN PHF3 TLN1 XRN1 KMT2A TLE6 LRBA	1.30e-06	422	119	13	int:WWTR1
Interaction	H3C1 interactions	LRWD1 WAPL CENPC ATAD5 C9orf78 AHCTF1 ZNF280C BARD1 TRIP12 KIF20B ANLN PHF3 ZNF638 KMT2A PRKCB CDC20 MGA SPEN ZNF292	1.35e-06	901	119	19	int:H3C1
Interaction	SMC5 interactions	ZNF777 WAPL CALD1 CENPC ATAD5 AHCTF1 ZNF280C REV3L TERF2 TRIP12 KIF20B TASOR2 PCF11 SCML2 ANLN PHF3 ZNF638 KMT2A MGA SPEN	1.55e-06	1000	119	20	int:SMC5
Interaction	ASF1A interactions	CALD1 CENPC ATAD5 KIF20B TASOR2 ANLN PHF3 KMT2A MGA SPEN	2.26e-06	249	119	10	int:ASF1A
Interaction	NUMA1 interactions	LRWD1 C9orf78 AHCTF1 ZNF280C BARD1 TERF2 TRIP12 BRDT ANLN TLN1 ASPM KMT2A MACF1	4.13e-06	469	119	13	int:NUMA1
Interaction	H2BC12 interactions	TRO AHCTF1 ANLN PHF3 XRN1 ZNF638 KMT2A PRKCB ANKRD36 SPAG17	2.16e-05	322	119	10	int:H2BC12
Interaction	H2BC3 interactions	WAPL ATAD5 BARD1 SRP68 TERF2 TRIP12 SCML2 MAGED2 KMT2A PRKCB CDC20	2.91e-05	406	119	11	int:H2BC3
Interaction	APEX1 interactions	WAPL ERCC5 CENPC ATAD5 AHCTF1 ZNF280C TERF2 TRIP12 KIF20B SCML2 CDCA7 ANLN PHF3 TLN1 ZNF638 KMT2A MED26 MGA ABCC10 ZNF292	5.24e-05	1271	119	20	int:APEX1
Interaction	NUP43 interactions	LRWD1 ERCC5 CENPC AHCTF1 ZNF280C TERF2 TRIP12 TASOR2 KMT2A HCFC2 MGA SPEN ZNF292	8.33e-05	625	119	13	int:NUP43
Interaction	FRY interactions	FRYL FRY CDC20	1.06e-04	16	119	3	int:FRY
Interaction	XRCC6 interactions	IKZF3 LRWD1 WAPL AHCTF1 ZNF280C BARD1 TERF2 TRIP12 PCF11 SCML2 ANLN PHF3 ZNF638 KMT2A MGA SPEN	1.13e-04	928	119	16	int:XRCC6
Interaction	DHX40 interactions	ERCC5 CENPC TERF2 TASOR2 PCF11 BRDT ZNF638 MGA	1.17e-04	249	119	8	int:DHX40
Interaction	MKI67 interactions	UTP6 VRK2 IKZF3 BARD1 TERF2 KIF20B ANLN ASPM KMT2A PRKCB CDC20 MGA SPEN	1.20e-04	648	119	13	int:MKI67
Interaction	SIRT7 interactions	UTP6 MAGED1 AHCTF1 SRP68 FRYL TRIP12 TASOR2 PHF3 TLN1 XRN1 ZNF638 KMT2A MACF1 SPEN	1.27e-04	744	119	14	int:SIRT7
Interaction	YWHAG interactions	TET2 BCL2L14 RTN3 FRYL TRIP12 ALMS1 CDCA7 PIK3C2A PIK3C3 ANLN PHF3 STARD9 ZNF638 KMT2A PRKCB MACF1 LRBA CDC20 ARAP2	1.27e-04	1248	119	19	int:YWHAG
Interaction	H1-4 interactions	IKZF3 SRP68 REV3L TASOR2 RPUSD4 ANLN PHF3 XRN1 ZNF638 KMT2A PRKCB MACF1 SPAG17	1.35e-04	656	119	13	int:H1-4
Interaction	H2BC4 interactions	TET2 TRO AHCTF1 PHF3 XRN1 ZNF638 KMT2A SPAG17	1.53e-04	259	119	8	int:H2BC4
Interaction	MDC1 interactions	CENPC ATAD5 BARD1 SRP68 TERF2 TRIP12 ANLN PHF3 CDC20 MGA	1.75e-04	414	119	10	int:MDC1
Interaction	UHRF2 interactions	KIF20B TASOR2 ANLN PHF3 ZNF638 KMT2A MGA	1.87e-04	200	119	7	int:UHRF2
Interaction	KCNA3 interactions	CALD1 AHCTF1 SRP68 CC2D1B AKAP12 MAGED2 PHF3 CCDC62 TLN1 XRN1 KMT2A MACF1 LRRC7 LRBA SPEN	1.90e-04	871	119	15	int:KCNA3
Interaction	CDK1 interactions	CCDC14 BCL2L14 LRWD1 CALD1 BARD1 KIF20B AKAP12 ANLN PRKCB CDC6 CDC20 REPS2	1.95e-04	590	119	12	int:CDK1
Interaction	NAA40 interactions	WAPL CALD1 ATAD5 AHCTF1 ZNF280C SRP68 AKAP12 SCML2 ALMS1 TLN1 XRN1 MASTL ZNF638 KMT2A MACF1 LRBA	2.06e-04	978	119	16	int:NAA40
Interaction	HNRNPCL2 interactions	UTP6 ATAD5 TRIP12 SCML2 PIK3C2A ANLN XRN1 FSBP	2.25e-04	274	119	8	int:HNRNPCL2
Interaction	FTL interactions	VRK2 TRO TTBK2 RPUSD4 ALMS1 ASPM AEBP2 MGA SENP5	2.25e-04	348	119	9	int:FTL
Interaction	MAGEA9 interactions	CCDC14 ATAD5 ZFHX4 PIK3C2A ASPM REPS2 SENP5	2.38e-04	208	119	7	int:MAGEA9
Interaction	USP7 interactions	TET2 BCL2L14 MAGED1 TRO ZNF280C SRP68 SP110 TRIP12 ZBBX SCML2 MAGED2 ANLN ASPM ZNF638 ZFHX2 MACF1 LRBA MED26 VPS13B	2.44e-04	1313	119	19	int:USP7
Interaction	YWHAH interactions	TET2 FRYL TRIP12 ALMS1 CDCA7 PIK3C2A PIK3C3 ANLN PHF3 STARD9 XRN1 ZNF638 KMT2A MACF1 LRBA CDC20 ARAP2	2.57e-04	1102	119	17	int:YWHAH
GeneFamily	WD repeat domain containing	LRWD1 KATNB1 NBEA TLE6 LRBA CDC20 WDR72	1.26e-04	262	77	7	362
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	NBEA CMYA5 AKAP12	2.51e-04	29	77	3	396
GeneFamily	Basic helix-loop-helix proteins\|MAX dimerization proteins	MGA MNT	3.71e-04	7	77	2	637
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2A PIK3C3	4.93e-04	8	77	2	831
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	6.32e-04	9	77	2	1230
GeneFamily	MAGE family	MAGED1 TRO MAGED2	6.55e-04	40	77	3	1136
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF20B STARD9 KIF28P	9.88e-04	46	77	3	622
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX4 ZFHX2	1.81e-03	15	77	2	529
GeneFamily	Fibronectin type III domain containing	MYLK TNC NCAM1 CMYA5	4.84e-03	160	77	4	555
GeneFamily	PHD finger proteins	SP110 PHF3 KMT2A	6.69e-03	90	77	3	88
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	WAPL CENPC AHCTF1 BARD1 FRYL REV3L TRIP12 KIF20B C2CD5 PCF11 NBAS FBXL7 PIK3C2A PIK3C3 PHF3 ZNF638 MACF1 SPEN MNT VPS13B ARAP2 ZNF292	6.69e-11	856	122	22	M4500
Coexpression	MENON_FETAL_KIDNEY_3_STROMAL_CELLS	MYLK CALD1 TNC NCAM1 AKAP12 MAGED2 MACF1	1.04e-07	81	122	7	M39253
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	WAPL CENPC FRYL REV3L PCF11 PIK3C3 PHF3 ZNF638 SPEN MNT VPS13B	1.67e-07	300	122	11	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	WAPL BARD1 FRYL REV3L TRIP12 KIF20B C2CD5 FBXL7 PIK3C3 PHF3 ZNF638 SPEN ZNF292	2.84e-07	466	122	13	M13522
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	WAPL CENPC FRYL REV3L PIK3C3 PHF3 ZNF638 VPS13B	4.09e-07	145	122	8	M1810
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 CALD1 ITGA1 CMYA5 FRY FBXL7 MACF1 ANKRD36 ANKRD12	6.92e-07	212	122	9	M39221
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	IKZF3 WAPL CENPC C9orf78 FRYL ITGA1 REV3L SP110 TRIP12 PCF11 PHF3 TLN1 XRN1 ZNF638 KMT2A PRKCB MACF1 LRBA SPEN VPS13B ARAP2 ZNF292	1.38e-06	1492	122	22	M40023
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20 ARAP2	1.46e-06	232	122	9	M45800
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	ERCC5 FRY BRDT PIK3C2A PRKCB HCFC2 LRBA ARAP2	4.57e-06	200	122	8	M9205
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	MYLK CALD1 ITGA1 AKAP12 FRY FBXL7 ANKRD36	8.37e-06	155	122	7	M39246
Coexpression	FAN_EMBRYONIC_CTX_MICROGLIA_1	CENPC ATAD5 BARD1 KIF20B ANLN ASPM CDC20	8.37e-06	155	122	7	M39041
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL	ATAD5 BARD1 KIF20B SCML2 CDCA7 ANLN ASPM MASTL ANKRD36 CDC6 CDC20	1.51e-05	478	122	11	M45785
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL	VRK2 MAGED1 ATAD5 AHCTF1 BARD1 RPUSD4 FRY ALMS1 CDCA7 ASPM CDC6 CDC20	1.69e-05	578	122	12	M45744
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	MAGED1 ATAD5 NCAM1 NBEA REV3L KIF20B C2CD5 ALMS1 ANLN ASPM PRKCB CDC6 CDC20	1.77e-05	680	122	13	MM456
Coexpression	VILLANUEVA_LIVER_CANCER_KRT19_UP	BARD1 KIF20B C2CD5 ALMS1 ANLN CDC20 ZNF292	1.84e-05	175	122	7	M336
Coexpression	LU_EZH2_TARGETS_DN	MAGED1 MYLK CALD1 RTN3 NBEA SCML2 CRCP MAGED2 ANLN LRBA	1.85e-05	400	122	10	M2140
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20 WDR72	1.93e-05	402	122	10	MM454
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 CENPC BARD1 FRYL TLN1 MACF1 ARAP2	2.21e-05	180	122	7	M8239
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	CALD1 ITGA1 AKAP12 FBXL7 PIK3C2A MACF1	4.49e-05	137	122	6	M39241
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	CALD1 TNC ITGA1 REV3L AKAP12	5.18e-05	86	122	5	M39247
Coexpression	KANG_DOXORUBICIN_RESISTANCE_UP	BARD1 ASPM CDC6 CDC20	1.18e-04	54	122	4	M1037
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	C5orf22 AHCTF1 KATNB1 BARD1 C2CD5 ALMS1 CDCA7 ANLN ASPM MASTL CDC6 CDC20	1.29e-04	714	122	12	M1744
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	TET2 ATAD5 BARD1 CDCA7 ANLN ASPM MASTL CDC6	1.39e-04	323	122	8	M2156
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	MAGED1 MYLK CALD1 PACSIN1 TNC NCAM1 NBEA CD209 NRK KMT2A PRKCB MACF1	1.41e-04	721	122	12	M1999
Coexpression	KIM_MYCN_AMPLIFICATION_TARGETS_DN	CCDC14 MYLK BARD1 AKAP12 XRN1	1.46e-04	107	122	5	M2919
Coexpression	FISCHER_DREAM_TARGETS	CCDC14 CENPC ATAD5 AHCTF1 BARD1 KIF20B PCF11 ALMS1 CDCA7 ANLN ASPM MASTL CDC6 CDC20	1.70e-04	969	122	14	M149
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	CALD1 NBEA ITGA1 AKAP12 FBXL7 ANKRD12	1.84e-04	177	122	6	M39245
Coexpression	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	BARD1 CDCA7 ANLN ASPM CDC6 CDC20	1.96e-04	179	122	6	M3268
Coexpression	BENPORATH_CYCLING_GENES	CCDC14 BARD1 OSER1 KIF20B PCF11 CDCA7 ANLN MASTL CDC6 CDC20 MNT	2.28e-04	648	122	11	M8156
Coexpression	LU_AGING_BRAIN_UP	EPM2A CALD1 FRYL PCF11 PIK3C2A PHF3 TLN1	2.37e-04	263	122	7	M5547
Coexpression	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	WAPL C5orf22 ATAD5 KATNB1 ITGA1 MASTL IGLC3 ANKRD12 HCFC2 CDC6	2.50e-04	548	122	10	MM1013
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	ERCC5 CALD1 CENPC AHCTF1 REV3L KIF20B TASOR2 ANLN PHF3 ASPM ZNF638	2.53e-04	656	122	11	M18979
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	TASOR2 SETDB2 SCML2 ALMS1 BRDT ANKRD12 MGA	2.56e-06	110	117	7	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	MYLK ATAD5 BARD1 NCAM1 ITGA1 TRIP12 AKAP12 TASOR2 SCML2 ZFHX4 ANLN NRK PRKCB HCFC2 CDC6 ARAP2 ZNF292	2.83e-06	826	117	17	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500	TNC NBEA TASOR2 PCF11 TTBK2 SCML2 ZFHX4 HCFC2 ZNF292	9.34e-06	247	117	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	TNC ZNF280C TIAM2 TASOR2 PCF11 TTBK2 SCML2 ZFHX4 HCFC2	9.97e-06	249	117	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	WAPL CENPC ATAD5 KIF20B PCF11 SETDB2 ALMS1 PIK3C2A ANLN ASPM ZNF638 ZNF292	1.10e-05	469	117	12	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	CENPC ATAD5 BARD1 KIF20B AKAP12 ALMS1 CDCA7 ANLN ASPM MASTL CDC20	1.28e-05	398	117	11	GSM399397_500
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	ATAD5 BARD1 KIF20B AKAP12 ALMS1 CDCA7 ANLN ASPM MASTL CDC6 CDC20	1.65e-05	409	117	11	GSM399452_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	MYLK CALD1 TNC BARD1 REV3L TRIP12 TASOR2 ZFHX4 PIK3C2A PHF3 NRK ASPM VPS13B ARAP2 ZNF292	3.70e-05	806	117	15	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	WAPL CENPC ATAD5 AHCTF1 KIF20B PCF11 ALMS1 ANLN PHF3 ASPM ZNF638 BBS12	3.81e-05	532	117	12	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3	IKZF3 ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	4.88e-05	380	117	10	GSM538207_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	UTP6 TNC ZNF280C TIAM2 TASOR2 PCF11 TTBK2 SCML2 ZFHX4 STARD9 HCFC2	6.81e-05	478	117	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3	ATAD5 BARD1 KIF20B ALMS1 CDCA7 ANLN ASPM MASTL CDC6 CDC20	7.03e-05	397	117	10	GSM791143_500
CoexpressionAtlas	B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3	ATAD5 BARD1 KIF20B AKAP12 CDCA7 ANLN ASPM MASTL CDC6 CDC20	7.48e-05	400	117	10	GSM538358_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	ATAD5 BARD1 KIF20B AKAP12 CDCA7 ANLN ASPM MASTL CDC6 CDC20	7.64e-05	401	117	10	GSM399450_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	ATAD5 BARD1 ITGA1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	9.18e-05	410	117	10	GSM538387_500
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	ATAD5 BARD1 KIF20B ALMS1 CDCA7 ANLN ASPM MASTL CDC6 CDC20	1.05e-04	417	117	10	GSM399403_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3	MAGED1 ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	1.10e-04	419	117	10	GSM476664_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500	TNC ZNF280C NBEA TIAM2 TASOR2 PCF11 TTBK2 SCML2 ZFHX4 HCFC2	1.30e-04	428	117	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	TET2 CENPC NBEA SP110 KIF20B ZFHX4 STARD9 NRK MACF1 ANKRD12 LRBA ZNF292	1.33e-04	607	117	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ATAD5 TRO REV3L KIF20B ZFHX4 MACF1 LRBA MGA MNT ZNF292	1.41e-04	432	117	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	BARD1 REV3L TRIP12 PIK3C2A PHF3 NRK ASPM VPS13B ZNF292	2.08e-04	369	117	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3	IKZF3 ATAD5 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	2.25e-04	373	117	9	GSM605781_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	CCDC14 WAPL C5orf22 TOM1L1 OSER1 SRP68 THYN1 ALMS1 PIK3C2A ANLN PHF3 ASPM MASTL ZNF638 ZFHX2	3.71e-04	994	117	15	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3	ATAD5 BARD1 CD209 CDCA7 ANLN ASPM MASTL CDC6 CDC20	3.83e-04	401	117	9	GSM791114_500
CoexpressionAtlas	Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	3.90e-04	402	117	9	GSM791105_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3	IKZF3 ATAD5 BARD1 ITGA1 KIF20B ANLN ASPM MASTL CDC6	3.90e-04	402	117	9	GSM605898_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	TASOR2 SETDB2 SCML2 ALMS1 BRDT	4.42e-04	115	117	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	4.83e-04	414	117	9	GSM476660_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	5.17e-04	418	117	9	GSM538350_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	5.26e-04	419	117	9	GSM538348_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500	SETDB2 SCML2 ALMS1 BRDT	5.43e-04	68	117	4	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	5.54e-04	422	117	9	GSM538357_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	5.54e-04	422	117	9	GSM538355_500
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	MAGED1 ATAD5 TOM1L1 NBEA KIF20B ALMS1 CDCA7 ANLN ASPM	5.63e-04	423	117	9	GSM791126_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	WAPL ALMS1 PIK3C2A ANLN PHF3 ASPM ZNF638	5.88e-04	259	117	7	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	CCDC14 WAPL BARD1 KIF20B C2CD5 TASOR2 SETDB2 SCML2 ALMS1 BRDT ANLN NRK MASTL	6.04e-04	822	117	13	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500	TNC NBEA TASOR2 PCF11 TTBK2 SCML2 ZFHX4 HCFC2 ZNF292	6.23e-04	429	117	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	SETDB2 SCML2 ALMS1 BRDT	6.75e-04	72	117	4	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000
CoexpressionAtlas	kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000	ATAD5 ZNF280C BARD1 KIF20B THYN1 ALMS1 ANLN MASTL	6.96e-04	348	117	8	gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000	ATAD5 TRIP12 TASOR2 SCML2 ZFHX4 HCFC2 CDC6 ZNF292	7.09e-04	349	117	8	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	WAPL CALD1 NBEA REV3L SP110 KIF20B ZFHX4 STARD9 NRK ZNF638 MACF1 ANKRD12	8.33e-04	744	117	12	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	TNC SP110 ZFHX4 NRK TLE6 MACF1 REPS2	8.54e-04	276	117	7	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4	TNC BARD1 FBXL7 TLE6 REPS2 LMNTD1	9.44e-04	204	117	6	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3	TNC NRK TLE6 LRBA REPS2	9.76e-04	137	117	5	Facebase_RNAseq_e9.5_Maxillary Arch_500_K3
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 CENPC FRYL SP110 TRIP12 PHF3 XRN1 KMT2A MACF1 ANKRD12 ARAP2 ZNF292	3.61e-13	200	122	12	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	IKZF3 AHCTF1 ITGA1 TASOR2 KMT2A MACF1 ANKRD36 ANKRD12 LRBA SPEN ARAP2	4.74e-12	188	122	11	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 NBEA FRYL REV3L XRN1 KMT2A PRKCB MACF1 MGA UNC80	1.68e-10	195	122	10	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FRYL AKAP12 XRN1 KMT2A MACF1 ANKRD36 ANKRD12 LRBA ARAP2 ZNF292	1.85e-10	197	122	10	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FRYL AKAP12 MACF1 ANKRD36 ANKRD12 LRBA VPS13B ARAP2 ZNF292	3.28e-09	193	122	9	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	3.59e-09	195	122	9	93c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 NBEA FRYL REV3L KMT2A PRKCB MACF1 MGA UNC80	3.59e-09	195	122	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IKZF3 ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	4.10e-09	198	122	9	d484ac79d6cd29f1d9c192d126c2099f737d5320
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IKZF3 ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	4.10e-09	198	122	9	ac0be1666456cfa8d68588b187d65008e6d5c0e2
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FRYL PHF3 MACF1 ANKRD36 ANKRD12 LRBA VPS13B ARAP2 ZNF292	4.28e-09	199	122	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CCDC14 CENPC ATAD5 BARD1 KIF20B ANLN ASPM CDC6 CDC20	4.47e-09	200	122	9	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SP110 PHF3 TLN1 XRN1 KMT2A MACF1 IGLC2 IGLC3 ANKRD12	4.47e-09	200	122	9	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	IKZF3 ITGA1 KMT2A MACF1 ANKRD36 ANKRD12 LRBA ARAP2	9.31e-09	151	122	8	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC4M KIF20B CDCA7 ANLN ASPM TLE6 CDC6 CDC20	2.46e-08	171	122	8	c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	IKZF3 AHCTF1 FRYL NBAS MACF1 LRBA SPEN ZNF292	4.53e-08	185	122	8	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	CCDC14 AHCTF1 FRYL NBAS MACF1 LRBA SPEN ZNF292	4.73e-08	186	122	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 TNC BARD1 KIF20B FBXL7 CDCA7 ANLN ASPM	4.93e-08	187	122	8	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 TNC BARD1 KIF20B FBXL7 CDCA7 ANLN ASPM	4.93e-08	187	122	8	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	5.35e-08	189	122	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MAGED1 MYLK CALD1 TNC NCAM1 AKAP12 MAGED2 MACF1	5.35e-08	189	122	8	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD5 BARD1 KIF20B CDCA7 ASPM MASTL CDC6 CDC20	5.80e-08	191	122	8	15dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	IKZF3 AHCTF1 FRYL NBAS MACF1 LRBA SPEN ZNF292	5.80e-08	191	122	8	9454f642c3621370fa23640b631301346b300950
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6	5.80e-08	191	122	8	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD5 BARD1 KIF20B CDCA7 ASPM MASTL CDC6 CDC20	5.80e-08	191	122	8	45c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PACSIN1 ATAD5 BARD1 CDCA7 ANLN ASPM CDC6 CDC20	6.29e-08	193	122	8	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CCDC14 REV3L KIF20B ALMS1 ANLN ASPM ANKRD36 CDC20	6.54e-08	194	122	8	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 REV3L AKAP12 FBXL7	6.81e-08	195	122	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IKZF3 CENPC KIF20B PHF3 KMT2A ANKRD36 ANKRD12 ZNF292	6.81e-08	195	122	8	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 REV3L AKAP12 FBXL7	6.81e-08	195	122	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-SEP / Disease, Lineage and Cell Type	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	7.36e-08	197	122	8	908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC6 CDC20	7.36e-08	197	122	8	7eb4c1cffd0366204af7e63adc8f751685601a94
ToppCell	E18.5-Mesenchymal\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAGED1 MYLK CALD1 TNC ITGA1 AKAP12 MAGED2 MACF1	7.66e-08	198	122	8	a16aa41eab2e297e56de43c22c355df0f79315da
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	7.66e-08	198	122	8	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	7.66e-08	198	122	8	48d39018c56ea8ba972c72af8ece10cbeb48fbc8
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	MYLK KIF20B AKAP12 ANLN ASPM PRKCB MACF1 CDC20	7.96e-08	199	122	8	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAGED1 MYLK CALD1 TNC NCAM1 AKAP12 MAGED2 MACF1	7.96e-08	199	122	8	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	7.96e-08	199	122	8	88d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	7.96e-08	199	122	8	446cd7d960812519fe2b8e434578ef0b668c75ce
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAGED1 MYLK CALD1 TNC NCAM1 AKAP12 MAGED2 MACF1	7.96e-08	199	122	8	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CCDC14 CENPC ATAD5 KIF20B ANLN ASPM CDC6 CDC20	7.96e-08	199	122	8	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CENPC ATAD5 BARD1 KIF20B ANLN ASPM CDC6 CDC20	7.96e-08	199	122	8	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	8.27e-08	200	122	8	0d9b8d51a7630e70e60c76c763ff82df4c559152
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	CENPC ATAD5 BARD1 KIF20B ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Transverse-Dendritic_cell-cycling_DCs\|Dendritic_cell / Region, Cell class and subclass	CCDC14 CENPC ATAD5 KIF20B CD209 ANLN ASPM CDC20	8.27e-08	200	122	8	617a6a42f7b31eb3c45bdceaf55a591b6de7f154
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells\|2m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	8.27e-08	200	122	8	0675f580ccef705875854247bbfd4ee2bcf126a1
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative\|Multiple_Sclerosis / Disease, condition lineage and cell class	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	7faf1e37364203a08d2b2544979e848b41e36b1c
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	8.27e-08	200	122	8	cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	ATAD5 BARD1 KIF20B ZFHX4 CDCA7 ASPM MASTL CDC20	8.27e-08	200	122	8	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Biopsy_IPF-Immune-Proliferating_T_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IKZF3 ATAD5 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative\|ICU-SEP / Disease, condition lineage and cell class	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	ae500c8b7c2162cadd31bf44ee9dc3271192cf17
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	55501f83409e0174c756a13ad8077f5b59975e27
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells\|6m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	8.27e-08	200	122	8	b9aad527d3ad5bc701e93fa2afdebf695b2a74bb
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BARD1 KIF20B ANLN ASPM MASTL CDC6 CDC20	8.27e-08	200	122	8	8f9e76048ae6f45218a09a95a2c4b31e8a8937b2
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	BCL2L14 IKZF3 MACF1 IGLC2 IGLC3 ANKRD36 ARAP2	2.52e-07	156	122	7	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 BARD1 ITGA1 CDCA7 ANLN ASPM CDC6	4.70e-07	171	122	7	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 BARD1 ITGA1 CDCA7 ANLN ASPM CDC6	4.70e-07	171	122	7	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 KIF20B ANLN ASPM MASTL LRRC7 CDC20	4.70e-07	171	122	7	4ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VRK2 ATAD5 BARD1 KIF20B ANLN MASTL CDC6	4.89e-07	172	122	7	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BARD1 CDCA7 ANLN ASPM CDC6 CDC20	5.28e-07	174	122	7	c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 TRO NCAM1 KIF20B ANLN ASPM CDC20	5.28e-07	174	122	7	41eb0a214a8b4015a26311f77061c8147144f0e7
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD5 APOF BARD1 CDCA7 ANLN CDC6 CDC20	5.49e-07	175	122	7	a6913f992a1ea20b43e5adeca3ede3a6fda820ad
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CENPC ITGA1 KIF20B ANLN ASPM CDC20	5.49e-07	175	122	7	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CENPC BARD1 KIF20B ANLN ASPM CDC20	5.71e-07	176	122	7	45c6983ab671b0f306e7390320bd84f848e474cc
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATAD5 BARD1 KIF20B CDCA7 ASPM CDC20 FSBP	6.39e-07	179	122	7	54621d2b3a66e62aa76b7e444118878ed97c1e02
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAGED1 MYLK CALD1 NCAM1 AKAP12 MAGED2 MACF1	6.39e-07	179	122	7	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BARD1 KIF20B CDCA7 ANLN ASPM CDC6	6.64e-07	180	122	7	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK CALD1 TNC NCAM1 ITGA1 SCML2 NRK	6.89e-07	181	122	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	ATAD5 BARD1 KIF20B CDCA7 ASPM CDC6 CDC20	7.41e-07	183	122	7	a48a6313f2f144586951cece97ec31f6d72361df
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP12 PHF3 TLN1 XRN1 ZNF638 KMT2A MACF1	7.69e-07	184	122	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	WAPL MYLK ITGA1 ALMS1 PIK3C2A ANKRD12 VPS13B	8.27e-07	186	122	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYLK CALD1 TNC ITGA1 AKAP12 FRY FBXL7	8.57e-07	187	122	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BARD1 KIF20B ANLN ASPM CDC6 CDC20	8.57e-07	187	122	7	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MYLK CALD1 TNC NCAM1 AKAP12 MAGED2 MACF1	8.88e-07	188	122	7	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 TNC KIF20B ANLN ASPM MASTL CDC20	8.88e-07	188	122	7	95d0a796d62ce6d121e2028c378faffc14b35275
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.20e-07	189	122	7	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BARD1 FBXL7 CDCA7 ANLN STARD9 ASPM	9.53e-07	190	122	7	31de1727822e9818652946dfb962daee77ffad68
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.53e-07	190	122	7	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IKZF3 MYLK CALD1 TNC TLN1 AEBP2 MACF1	9.53e-07	190	122	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.53e-07	190	122	7	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ATAD5 BARD1 ANLN ASPM MASTL LRRC7 CDC6	9.53e-07	190	122	7	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.88e-07	191	122	7	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	ATAD5 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	9.88e-07	191	122	7	210a0f1a71df2508cbfc73d6868a2122338b9a1c
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IKZF3 ATAD5 BARD1 KIF20B ANLN ASPM PRKCB	9.88e-07	191	122	7	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.88e-07	191	122	7	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK CALD1 TNC NCAM1 ITGA1 FBXL7 PRKCB	9.88e-07	191	122	7	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATAD5 KIF20B CDCA7 ANLN ASPM CDC6 CDC20	1.02e-06	192	122	7	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 TNC KIF20B ANLN ASPM MASTL CDC20	1.06e-06	193	122	7	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	TNC BARD1 KIF20B ANLN ASPM CDC6 CDC20	1.06e-06	193	122	7	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK CALD1 TNC ITGA1 REV3L AKAP12 LRRC7	1.06e-06	193	122	7	5578f7cb3ec68c9a38cc5304b618b81283024d5e
ToppCell	(1)_T_cells_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ATAD5 BARD1 KIF20B CDCA7 ASPM CDC6 CDC20	1.10e-06	194	122	7	8f313071933451780309d2174ed27d8cdc734343
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 TNC NCAM1 ITGA1 AKAP12 FBXL7 PRKCB	1.10e-06	194	122	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAGED1 MYLK CALD1 NCAM1 AKAP12 MAGED2 MACF1	1.10e-06	194	122	7	f2f7b9aad7588c8020a4850ff9333e1db8eafac7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 TNC NCAM1 ITGA1 AKAP12 FBXL7 PRKCB	1.10e-06	194	122	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CALD1 ITGA1 KIF20B MAGED2 ANLN ASPM CDC20	1.10e-06	194	122	7	d840c1949c328779426c9172e02da09e968f0567
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF20B CDCA7 ANLN ASPM IGLC2 IGLC3 CDC20	1.10e-06	194	122	7	06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|367C / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 BARD1 KIF20B ANLN ASPM CDC6 CDC20	1.10e-06	194	122	7	a12b64945e10f00aa983678a02586c59badc1570
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 TNC NCAM1 ITGA1 AKAP12 FBXL7 PRKCB	1.13e-06	195	122	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ATAD5 KIF20B ANLN ASPM MASTL CDC6 CDC20	1.13e-06	195	122	7	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-proliferating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BARD1 KIF20B CDCA7 ANLN ASPM MASTL CDC20	1.13e-06	195	122	7	b57132802cb977551e214880984f3edcd375474f
ToppCell	P03-Mesenchymal\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAGED1 MYLK CALD1 TNC AKAP12 MAGED2 MACF1	1.13e-06	195	122	7	6180309c6ae278b996fd98c57461cbc129c028ba
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATAD5 AHCTF1 TASOR2 PHF3 ZNF638 KMT2A MACF1 SPEN	1.46e-09	50	74	8	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	IKZF3 PHF3 KMT2A MACF1 ZNF292	2.03e-05	49	74	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KIF20B ANLN ASPM CDC20	3.47e-04	49	74	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE
Drug	Clorgyline	CENPC ZNF280C REV3L PIK3C2A PHF3 ZNF638 ANKRD12 ARAP2 ZNF292	2.35e-07	168	118	9	ctd:D003010
Drug	geldanamycin	TET2 C5orf22 CALD1 FRYL ITGA1 NBAS ZFHX4 CRCP NRK ASPM ZNF638 KMT2A	5.31e-07	371	118	12	ctd:C001277
Drug	Vincristine	CALD1 CENPC BARD1 ITGA1 TASOR2 PCF11 FRY ALMS1 CDCA7 PIK3C2A ASPM ZNF638 MACF1 LRBA CDC6 MGA ABCC10 ARAP2 WDR72	1.04e-05	1182	118	19	ctd:D014750
Disease	extrapulmonary tuberculosis (is_implicated_in)	CLEC4M CD209	4.66e-05	3	117	2	DOID:0050598 (is_implicated_in)
Disease	carnitine measurement	MSH4 RPUSD4 NRK ABCC10	2.42e-04	76	117	4	EFO_0010469
Disease	microcephaly (implicated_via_orthology)	KATNB1 KIF20B ASPM	2.77e-04	32	117	3	DOID:10907 (implicated_via_orthology)
Disease	physical activity	PCF11 AEBP2 LRRC7 ARAP2	4.24e-04	88	117	4	EFO_0003940
Disease	Mycobacterium tuberculosis, susceptibility to	SP110 CD209	6.87e-04	10	117	2	cv:C1834752
Disease	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	SP110 CD209	6.87e-04	10	117	2	607948
Disease	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)	SP110 CD209	6.87e-04	10	117	2	C1834752
Disease	coffee consumption measurement, tea consumption measurement	TET2 NCAM1 XRN1	7.15e-04	44	117	3	EFO_0006781, EFO_0010091
Disease	Umbilical hernia	CALD1 ZC3H11B	8.38e-04	11	117	2	HP_0001537
Disease	body weight	TET2 ATAD5 TOM1L1 ZNF280C SPATA31C2 TRIP12 NBAS RPUSD4 ANLN PHF3 ZNF638 MGA CDH9	1.50e-03	1261	117	13	EFO_0004338
Disease	amyotrophic lateral sclerosis, age at onset	CCDC192 ARAP2	1.58e-03	15	117	2	EFO_0004847, MONDO_0004976
Disease	Inherited oocyte maturation defect	TLE6 CDC20	1.80e-03	16	117	2	cv:CN238505
Disease	colorectal cancer, inflammatory bowel disease	SP110 ALMS1	2.55e-03	19	117	2	EFO_0003767, MONDO_0005575
Disease	hemorrhoid	TET2 ZC3H11B NCAM1 FBXL7	2.84e-03	147	117	4	EFO_0009552
Disease	pulse pressure measurement	TET2 ZC3H11B NCAM1 NBEA FRYL ITGA1 TERF2 FBXL7 ZFHX4 CDCA7 PIK3C2A ZNF638 ABCC10	3.54e-03	1392	117	13	EFO_0005763
Disease	Malignant neoplasm of breast	BARD1 SP110 AKAP12 LIPE MAGED2 MACF1 LRRC7 LRBA REPS2 SPEN VPS13B	3.66e-03	1074	117	11	C0006142
Disease	peak expiratory flow	UTP6 TET2 ITGA1 RPUSD4 FRY BRDT XRN1	3.77e-03	498	117	7	EFO_0009718
Disease	alcohol consumption measurement	VRK2 WAPL ZC3H11B NCAM1 NBEA NBAS ALMS1 BRDT XRN1 ANKRD36 MGA ARAP2	3.86e-03	1242	117	12	EFO_0007878

Protein segments in the cluster

Peptide	Gene	Start	Entry
SDPENEQTVQKRKSN	ATAD5	356	Q96QE3
LKKTQNDPTNETSVF	EPM2A	321	B3EWF7
QNSSKVSSQPKAKEE	AEBP2	356	Q6ZN18
SKENQPENSQTPTKK	CDC20	96	Q12834
ASVQTQPAIKKDASA	BARD1	161	Q99728
TNKSEVPEESAQKNT	CCDC62	666	Q6P9F0
QQNIAVSSAKEKSSP	BRDT	151	Q58F21
QKSAEQPEQKAATEV	AKAP12	866	Q02952
QDQKDANISQPETTK	APOF	261	Q13790
KENIVNSFTDKQQTP	MASTL	506	Q96GX5
ENVESRSKKENVPNT	ALMS1	3966	Q8TCU4
ANSSNPKKAAEITVI	C17orf78	256	Q8N4C9
EKEDSQSTPAKVSAQ	BCL2L14	101	Q9BZR8
QSLTSQSQAVVTPEK	ARAP2	576	Q8WZ64
VSSQKQPALKATTDE	ANKRD36	681	A6QL64
SKVPSSISQEQSRQD	CD209	61	Q9NNX6
PKDAVSNRSQSVDTK	ANKRD12	1156	Q6UB98
KPSVLQNKQDTEAFT	C7orf31	486	Q8N865
KPQTKVEADNNTSRT	BBS12	201	Q6ZW61
VQKETSSSDNKKQIP	CCDC14	161	Q49A88
KQNNPKFSAVQDISS	ASPM	466	Q8IZT6
SIQEPKEANSTKAQK	H2BW2	21	P0C1H6
AASRTQVQKANSPEK	LRWD1	201	Q9UFC0
SATAQSVQNPEKTKE	ABCC10	831	Q5T3U5
FESKPQSQEVKENQT	MYLK	416	Q15746
PNSINDTINSTKTEQ	HCFC2	426	Q9Y5Z7
DTINSTKTEQPATKE	HCFC2	431	Q9Y5Z7
DTTKAPTADTQTQNV	MAGED1	186	Q9Y5V3
DTKVNTKAQETEAAP	MAGED2	131	Q9UNF1
QPQTEKTKQSCVEEQ	MEPE	21	Q9NQ76
ESQNPDQKDETNSIK	MGA	1971	Q8IWI9
VENSNPTANTEQTVK	LRRC7	596	Q96NW7
SKTQSLPVTEKVTEN	ANLN	481	Q9NQW6
KVTENQIPAKNSSTE	ANLN	491	Q9NQW6
EKTQKVENPSVSFAS	CFAP65	11	Q6ZU64
STTCSKPQRVKQNSE	KATNB1	341	Q9BVA0
SKVSNLQVSPKSEDI	PIK3C2A	251	O00443
DINSPINAKKVNTTT	FRYL	841	O94915
SNVEASKENVSQPKR	KIF20B	1761	Q96Q89
ATPSVSVSKNVNVKD	LRBA	1666	P50851
NIPNVDDKKTSNLSV	MNT	246	Q99583
TASTATITKEKQDQP	LMNTD1	286	Q8N9Z9
VPEEKTTNTVSKFDN	PRKCB	316	P05771
PRNTTFNVESTKKNE	ITGA1	416	P56199
KQEAKASLQSPFEQT	MED26	461	O95402
EKPISFVKNTQSSSE	NBAS	1056	A2RRP1
SPTKTETVKAQAESN	MACF1	4496	Q9UPN3
NSKTEQSVTPEQQKK	PACSIN1	176	Q9BY11
NQHSTKSGTEPKENV	PCF11	571	O94913
QTLVPNTDQKSTSVK	CASP5	46	P51878
KTSVSQNVIPSSAQK	CENPC	166	Q03188
PTKAQKNVATSEDSD	FBXL7	31	Q9UJT9
ATPVSEQFSSSQKQK	CMYA5	1051	Q8N3K9
IQTSKDDTSDVPKQS	CMYA5	2851	Q8N3K9
AGVETTTPSKQSNNK	IGLC2	51	P0DOY2
NNQEENDAVSSAKKP	C5orf22	166	Q49AR2
AGVETTTPSKQSNNK	IGLC3	51	P0DOY3
SKTAVVKNTNSPEFD	CC2D1B	741	Q5T0F9
AKNSSDAKLEPTNVQ	CDC6	26	Q99741
SSVVKNVVDSSQKPT	KMT2A	1231	Q03164
LPSAVTSDQKSQKVD	AHCTF1	1641	Q8WYP5
EDITPKNQNSKSAEQ	FRY	1811	Q5TBA9
SESDIPQENKVSKAS	CCDC192	46	P0DO97
TNAELKSTQEQSVPA	IKZF3	6	Q9UKT9
ITVTATEINNPKQSS	CDH9	456	Q9ULB4
FDKNQALQTTKTPVE	C2CD5	796	Q86YS7
STVKDISQAASNQIP	KIF28P	811	B7ZC32
SQKEPRAQQKSASQE	LIPE	71	Q05469
QVSKKQQAQTQTSEP	NRK	496	Q7Z2Y5
EQDTKKEPVSTNAVQ	RPUSD4	56	Q96CM3
PQVKQQTDKSSDCIT	RTN3	346	O95197
SQTEEQPTTKQAKAV	UTP6	286	Q9NYH9
VNQTPSEQTKGKASS	TEX55	106	Q96M34
AEPEAEQKKNTNSNV	CRCP	126	O75575
QNKNQKEATNTTSEP	TOM1L1	296	O75674
QISKAQDDSSQTVKP	TMCO5B	201	A8MYB1
VQKSQDVFSVSTPNL	SPATA31C2	416	B4DYI2
VQVEVAEKVQKSSSP	NBPF12	716	Q5TAG4
VKKSQESLTENPSET	NBEA	1711	Q8NFP9
EPTKKDSQSSVSENV	PIK3C3	416	Q8NEB9
ASDSQNSVKEAPVKN	ERCC5	1126	P28715
PKQDTVNAAESKITN	MSH4	406	O15457
NSKIASSQQVTAEIP	STARD9	1806	Q9P2P6
DQVPQKKDDSTCNST	SP110	316	Q9HB58
SKKEDSSDATQVPQA	OSER1	161	Q9NX31
TETSSSQVKDNKPLV	SRP68	541	Q9UHB9
QQKSETIPSEITNTK	SPAG17	1341	Q6Q759
QNSVPDEEAKTTTTN	CALD1	71	Q05682
NKKAESRQPSENSVT	CDCA7	86	Q9BWT1
QVSKVPSSLSQEQSE	CLEC4M	71	Q9H2X3
VKTVPNDATQTKENE	NCAM1	841	P13591
VKTTQTSNAPDVNDA	UHRF1BP1L	291	A0JNW5
KNSQKASPVDDEQLS	SENP5	486	Q96HI0
VTQKEQENKSNAFPS	SETDB2	86	Q96T68
VQAKTSKVESDQPQN	ZFHX4	3296	Q86UP3
NDKNQEKDESTPVSN	UNC80	771	Q8N2C7
TPEKDAQNKTEQLAS	ZFHX2	946	Q9C0A1
KKNTANDFSNVPDIT	TIAM2	1016	Q8IVF5
EFQQSVSKSQVKPDS	SPEN	2846	Q96T58
VSKSQVKPDSVTASQ	SPEN	2851	Q96T58
PNQDVTSDDKQALKS	REPS2	416	Q8NFH8
KNQFAAVNTPQKETS	REV3L	2251	O60673
NTQASSVTAQPKKAN	TRO	126	Q12816
DVKKENQEKTPQSST	SCML2	11	Q9UQR0
EDSVSPKKSTVLQQQ	TLN1	421	Q9Y490
TKTQTFSVVPNQDKN	TTBK2	826	Q6IQ55
QKETQSDFKSNISEP	FSBP	86	O95073
AEVDVPKSQQATTKT	TNC	936	P24821
SAVKEDKESNPATIN	TNC	966	P24821
SSTNAQQSAPEKVKK	ZNF292	1331	O60281
KSQSENVPASRSTQV	ZNF292	1991	O60281
STSVQENKEQSRPFV	WDR72	311	Q3MJ13
KNFENKEAQSSQATP	XRN1	1616	Q8IZH2
NADDSTKKPNAETTV	WAPL	186	Q7Z5K2
KSVKRNTDVPESQQN	PHF3	526	Q92576
QLPTKSSQKVEVETS	ZC3H11B	611	A0A1B0GTU1
ALAKVEDSNPQKTSA	THYN1	31	Q9P016
PVEKNQTFKSEQSSD	VPS13B	2286	Q7Z7G8
VNVSVKQQTSPKSSQ	TASOR2	1601	Q5VWN6
QQNKKKDSETSFVPT	C9orf78	201	Q9NZ63
VENASKPDFTKNSQV	ZNF280C	121	Q8ND82
QKDTPFQISSAVQKE	ZNF777	161	Q9ULD5
DDKVDNQAKSPTTTQ	TRIP12	1021	Q14669
PSRTKQTENASQAKQ	TET2	1496	Q6N021
AAPDEDSTTNITKKQ	TERF2	476	Q15554
TPNSQKVDSQKAATK	VRK2	336	Q86Y07
VKQSSVTQVTEQSPK	ZNF638	116	Q14966
PKEENNSTKETSKIQ	ZBBX	201	A8MT70
TPQQVKDKTLQESSF	TLE6	106	Q9H808
NQTTSVKKEETPSAI	LEUTX	81	A8MZ59